Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

SHA:600671 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	44.8	31.89	65.72	97.96	42.39	22.29
Cash & Short-Term Investments	44.8	31.89	65.72	97.96	42.39	22.29
Cash Growth	21.92%	-51.48%	-32.91%	131.09%	90.18%	194.31%
Accounts Receivable	158.53	146.69	97.97	36.96	30.99	51.83
Other Receivables	1.52	1.34	2.56	2	1.79	54.92
Receivables	160.06	148.03	100.54	38.96	32.78	106.75
Inventory	41.6	39.18	52.32	42.95	47.56	52.36
Prepaid Expenses	-	-	-	-	0.03	-
Other Current Assets	10.14	9.37	4.13	1.63	1.37	4.68
Total Current Assets	256.59	228.48	222.71	181.5	124.13	186.08
Property, Plant & Equipment	189.61	193.85	192.86	151.66	164.94	199.82
Goodwill	1.61	1.61	1.61	2.2	2.2	3.31
Other Intangible Assets	4.97	5.01	5.09	5.21	5.37	5.52
Long-Term Deferred Tax Assets	9.06	9.86	7.14	3.51	3.45	1.98
Long-Term Deferred Charges	2.99	3.16	12.05	2.2	2.48	5.93
Other Long-Term Assets	0.06	0.06	-	-	-	-
Total Assets	464.88	442.03	441.46	346.29	302.57	402.65

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	73.82	60.75	58.35	44.71	35.92	48.97
Accrued Expenses	3.35	12.64	14.24	12.6	15.13	13.92
Short-Term Debt	178.92	144.3	128.91	102.94	105.14	108.15
Current Portion of Leases	12.56	12.84	13.11	4.44	3.44	1
Current Income Taxes Payable	8.78	4.39	10.44	3.02	0.3	0.66
Current Unearned Revenue	3.65	3.35	2.45	3.39	3.58	2.99
Other Current Liabilities	24.43	44.16	58.88	49.28	57.71	75.45
Total Current Liabilities	305.51	282.42	286.38	220.38	221.22	251.15
Long-Term Leases	7.51	8.65	10.34	7.23	7.46	4.55
Long-Term Unearned Revenue	45.17	46.65	52.63	58.62	65.25	78.71
Long-Term Deferred Tax Liabilities	7.26	7.96	6.14	2.97	2.65	-
Other Long-Term Liabilities	2.36	2.36	0.95	1.15	1.43	3.68
Total Liabilities	367.8	348.04	356.44	290.34	298.01	338.09

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	121.78	121.78	121.78	121.78	121.78	121.78
Additional Paid-In Capital	162.79	162.79	162.79	162.79	72.79	65.04
Retained Earnings	-210.74	-214.56	-232.18	-247.43	-209.15	-141.63
Total Common Equity	73.82	70.01	52.38	37.14	-14.59	45.18
Minority Interest	23.26	23.99	32.64	18.81	19.15	19.37
Shareholders' Equity	97.08	93.99	85.02	55.95	4.56	64.56
Total Liabilities & Equity	464.88	442.03	441.46	346.29	302.57	402.65

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	198.99	165.79	152.35	114.61	116.04	113.7
Net Cash (Debt)	-154.19	-133.91	-86.63	-16.65	-73.65	-91.41
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.27	-1.10	-0.71	-0.14	-0.60	-0.74
Filing Date Shares Outstanding	121.78	121.78	121.78	121.78	121.78	121.78
Total Common Shares Outstanding	121.78	121.78	121.78	121.78	121.78	121.78
Working Capital	-48.92	-53.95	-63.67	-38.88	-97.09	-65.08
Book Value Per Share	0.61	0.57	0.43	0.30	-0.12	0.37
Tangible Book Value	67.24	63.38	45.68	29.72	-22.16	36.34
Tangible Book Value Per Share	0.55	0.52	0.38	0.24	-0.18	0.30
Buildings	-	107.1	107.1	107.1	107.1	117.62
Machinery	-	140.38	141.27	103.57	109	117.51
Construction In Progress	-	18.11	1.25	0.02	0.11	8.62

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error